Instead, the substance is being moved into the PCAC review pipeline, where independent experts will evaluate whether it should be approved for legal compounding under Section 503A
The seven peptides FDA's Pharmacy Compounding Advisory Committee reviewing Thursday and Friday:
We believe that this attention to detail is what sets us apart and helps ensure the integrity of the research being conducted
Dosage modifications are not recommended for patients with concomitant use of CYP3A4 inhibitors, CYP2D6 inhibitors or CYP3A4 inducers for less than 14 days
demonstrated that culturing ciPTEC-OAT1 in an OrganoPlate, a 3D platform consisting of 96 chips that provides fluid shear stress by placing the plate on a rocker platform, it was possible to create a high-throughput screening method compatible with advanced imaging techniques (Vriend et al
The finding comes days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding